Bio-Rad Laboratories, Inc. 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 7:06 pm Purchase |
2025-02-10 | 13G | OncoCyte Corporation OCX |
BIO RAD LABORATORIES INC BIO |
2,764,078 9.700% |
1,253,134 (+82.94%) |
Filing |
| 2024-10-24 12:13 pm Purchase |
2024-10-04 | 13G | OncoCyte Corporation OCX |
BIO RAD LABORATORIES INC BIO |
1,510,944 8.970% |
1,510,944 (New Position) |
Filing |